Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking

Cancer

Volumn 80, Issue 5, 1997, Pages 852-857

  Nimura, Yoshinori ^a   Yokoyama, Shiro ^a   Fujimori, Minoru ^a   Aoki, Takahisa ^a   Adachi, Wataru ^a   Nasu, Tamie ^a   He, Ming ^b   Ping, Yu Min ^b   Iida, Futoshi ^c  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c Nagano Cancer Detection Center   (Japan)

Author keywords

Cytochrome P450; Esophageal carcinoma; Glutathione S transferase; Polymorphism; Smoking

Indexed keywords

AROMATIC HYDROCARBON; BENZO[A]PYRENE; CYTOCHROME P450; GENE PRODUCT; GLUTATHIONE TRANSFERASE; TOBACCO SMOKE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; ENZYME METABOLISM; ESOPHAGUS CARCINOMA; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; BENZO(A)PYRENE; BIOTRANSFORMATION; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CYTOCHROME P-450 ENZYME SYSTEM; ESOPHAGEAL NEOPLASMS; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; ISOLEUCINE; MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; VALINE;

EID: 0030876718     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970901)80:5<852::AID-CNCR4>3.0.CO;2-N     Document Type: Article

References (27)

1. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Benichou J, Dai Q, et al. Risk factors for esophageal cancer in shanghai, China. I. role of cigarette smoking and alcohol drinking. Int J Cancer 1994;58:192-6.
2. Brown LM, Hoover RN, Greenberg RS, Schoenberg JB, Schwartz AG, Swanson GM, et al. Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use? J Natl Cancer Inst 1994;86:1340-5.
3. McManus ME, Burgess WM, Veronese ME, Huggett A, Quattrochi LC, Tukey RH. Metabolism of 2-acetylaminofluorene and benzo[a]pyrene and activation of food-derived heterocyclic amine mutagens by human cytochrome P450. Cancer Res 1990;50:3367-76.
4. Kouri RE, McKinney CE, Slomiany DJ, Snodgrass DR, Wray NP, McLemore TL. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res 1982;42:5030-7.
5. Mannervik B, Danielson UH. Glutathione transfereses: structure and catalytic activity. CRC Crit Biochem 1988;23: 281-337.
6. Hayashi SI, Watanabe I, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated Msp I polymorphisms with amino acid replacement in the heme binding region of the human Cytochrome P450IA1 gene. J Biochem (Tokyo) 1991; 110:407-11.
7. Hayashi SI, Watanabe J, Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione s-transferase genes. Jpn J Cancer Res 1992;83:866-70.
8. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 1990;263:131-3.
9. Nakachi K, Imai K, Hayashi SI, Kawajiri K. Polymorphisms of the CYP1A1 and glutathione s-transferese genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 1993;53:2994-9.
10. Nazar-Stewart V, Motulsky AG, Eaton DL, White E, Hornung SK, Leng ZT, et al. The glutathione s-transferase μ polymor-phism as a marker for susceptibility to lung carcinoma. Cancer Res 1993;53:2313-8.
11. Zhong S, Howie AF, Ketterer B, Taylor J, Hayes JD, Beckett GJ, et al. Glutathion S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 1991;12:1533-7.
12. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993; 14:1479-81.
13. Seidegård J, Pero RW, Miller DG, Beattie EJ. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986;7:751-3.
14. Seidegård J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ. Isoenzyme(s) of glutathione transferese (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis 1990;11:33-6.
15. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione s-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993;85: 1159-64.
16. Brockmöller J, Kerb R, Drakoulis N, Staffeldt B, Roots I. Glutathione s-transferese M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 1994;54:4103-11.
17. Murray GI, Paterson PJ, Weaver RJ, Ewen SWB, Melvin WT, Burke MD. The expression of cytochrome P-450, epoxide hydrolase, and glutathione s-transferase in hepatocellular carcinoma. Cancer 1993;71:36-43.
18. Tanita J, Tsuchida S, Hozawa J, Sato K. Expression of glutathione s-transferase-π in human squamous cell carcinomas of the pharynx and larynx. Cancer 1993;72:569-76.
19. Heagerty AHM, Fitzgerald D, Smith A, Bowers B, Jones P, Fryer AA, et al. Glutathione s-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet 1994;343: 266-8.
20. Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, Moore DF, et al. Glutathione s-transferase activity and glutathione s-transferase μ expression in subjects with risk for colorectal cancer. Cancer Res 1995;55:2789-93.
21. Tsuchida S, Sekine Y, Shineha R, Nishihira T, Sato K. Elevation of the placental glutathione s-transferase from (GST-π) in tumor tissues and the levels in sera of patients with cancer. Cancer Res 1989;49:5225-9.
22. Peters WHM, Wobbes T, Roelofs HMJ, Jansen JBMJ. Glutathione s-transferases in esophageal cancer. Carcinogenesis 1993;14:1377-80.
23. Murray GI, Shaw D, Weaver RJ, McKay JA, Ewen SWB, Melvin WT, et al. Cytochrome P450 expression in oesophageal cancer. Gut 1994;35:599-603.
24. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, et al. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 1990;50:7184-9.
25. Hayashi SI, Watanabe J, Nakachi K, Kawajiri K. PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res 1991;19:4797.
26. Seidegård J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988;85:7293-7.
27. Lai HCJ, Qian B, Grove G, Tu CPD. Gene expression of rat glutathione s-transferases. J Biol Chem 1988;263:11389-95.